Catalyst Biosciences Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Nassim Usman
Chief executive officer
US$2.4m
Total compensation
CEO salary percentage | 24.9% |
CEO tenure | 8.2yrs |
CEO ownership | 0.09% |
Management average tenure | no data |
Board average tenure | 8.2yrs |
Recent management updates
Recent updates
Catalyst Biosciences declares special one-time dividend of $1.43
Aug 25Catalyst Biosciences: Shareholders Should Reap Benefits From Owning The Stock
Aug 15Catalyst Biosciences plans to distribute $65M cash to stockholders
Jun 29Companies Like Catalyst Biosciences (NASDAQ:CBIO) Could Be Quite Risky
Jan 11Circling Back On Catalyst Biosciences
Dec 08Shareholders May Not Be So Generous With Catalyst Biosciences, Inc.'s (NASDAQ:CBIO) CEO Compensation And Here's Why
Jun 03Catalyst Biosciences (NASDAQ:CBIO) Will Have To Spend Its Cash Wisely
May 18Catalyst Biosciences EPS misses by $0.12, beats on revenue
May 06Would Shareholders Who Purchased Catalyst Biosciences' (NASDAQ:CBIO) Stock Five Years Be Happy With The Share price Today?
Mar 09We're Hopeful That Catalyst Biosciences (NASDAQ:CBIO) Will Use Its Cash Wisely
Feb 01Catalyst Biosciences announces closing of $50M capital raise
Jan 29Do Institutions Own Catalyst Biosciences, Inc. (NASDAQ:CBIO) Shares?
Dec 28Catalyst Biosciences' MarzAA fast track'd for episodic bleeding in hemophilia patients
Dec 02What We Learned About Catalyst Biosciences' (NASDAQ:CBIO) CEO Pay
Dec 02Catalyst Biosciences (CBIO) Presents At Stifel 2020 Virtual Healthcare Conference - Slideshow
Nov 18Catalyst Biosciences: After 2 Fundraisings, A Lengthy Wait For Pivotal Trial Data Is Next
Nov 14CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2023 | n/a | n/a | -US$44m |
Jun 30 2023 | n/a | n/a | -US$48m |
Mar 31 2023 | n/a | n/a | US$7m |
Dec 31 2022 | US$2m | US$595k | -US$8m |
Sep 30 2022 | n/a | n/a | US$12m |
Jun 30 2022 | n/a | n/a | -US$8m |
Mar 31 2022 | n/a | n/a | -US$80m |
Dec 31 2021 | US$1m | US$595k | -US$88m |
Sep 30 2021 | n/a | n/a | -US$87m |
Jun 30 2021 | n/a | n/a | -US$77m |
Mar 31 2021 | n/a | n/a | -US$75m |
Dec 31 2020 | US$1m | US$574k | -US$56m |
Sep 30 2020 | n/a | n/a | -US$51m |
Jun 30 2020 | n/a | n/a | -US$48m |
Mar 31 2020 | n/a | n/a | -US$44m |
Dec 31 2019 | US$1m | US$525k | -US$55m |
Sep 30 2019 | n/a | n/a | -US$52m |
Jun 30 2019 | n/a | n/a | -US$47m |
Mar 31 2019 | n/a | n/a | -US$40m |
Dec 31 2018 | US$2m | US$481k | -US$30m |
Sep 30 2018 | n/a | n/a | -US$25m |
Jun 30 2018 | n/a | n/a | -US$23m |
Mar 31 2018 | n/a | n/a | -US$26m |
Dec 31 2017 | US$2m | US$464k | -US$26m |
Sep 30 2017 | n/a | n/a | -US$24m |
Jun 30 2017 | n/a | n/a | -US$22m |
Mar 31 2017 | n/a | n/a | -US$17m |
Dec 31 2016 | US$570k | US$453k | -US$17m |
Compensation vs Market: Nassim's total compensation ($USD2.39M) is above average for companies of similar size in the US market ($USD738.70K).
Compensation vs Earnings: Nassim's compensation has increased whilst the company is unprofitable.
CEO
Nassim Usman (63 yo)
8.2yrs
Tenure
US$2,392,782
Compensation
Dr. Nassim Usman, Ph.D. serves as a Venture Partner at Morgenthaler Ventures. Dr. Usman is a part of the life sciences team. He joined Morgenthaler as an Entrepreneur-in-Residence in 2005 and has also serv...
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 8.2yrs | US$2.39m | 0.090% $ 17.5k | |
Independent Chairman of the Board | 17.7yrs | US$91.00k | 0.13% $ 24.9k | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | 7.1yrs | US$695.83k | no data | |
Independent Director | less than a year | no data | no data | |
Independent Director | less than a year | no data | no data | |
Member of Scientific Advisory Board | 14.6yrs | no data | no data | |
Member of Scientific Advisory Board | 14.6yrs | no data | no data | |
Member of Scientific Advisory Board | 14.6yrs | no data | no data | |
Independent Director | 6yrs | US$50.00k | 0.074% $ 14.4k |
8.2yrs
Average Tenure
67yo
Average Age
Experienced Board: CBIO's board of directors are considered experienced (8.2 years average tenure).